Infectious diseases Archives - Page 6 of 34

Clinical Articles

From FLiRT to FLuQE: what to know about the latest COVID variants on the rise

The latest variant is nicknamed “FLuQE”, and is reportedly gaining traction in Australia and other countries. So what is there to know about FLuQE?

Podcasts

COVID & Bird Flu update – New variants, new vax schedule, antivirals

Prof Adrian Esterman provides relevant updates for COVID, respiratory infections, flu, and the latest in antivirals.

Clinical Articles

First human bird flu case reported in Victoria

Here’s what we know so far...

Clinical Articles

AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation

The development has been covered in various media outlets as primarily related to the known “adverse events”, namely the small risk of blood clots. However, other factors are far more likely to be driving this decision...

Podcasts

Long COVID update

Listen to the latest on Long COVID, with Dr Gary Grohmann, where we address the important considerations for Long COVID, what we know now, and how to treat, prevent and reduce the severity of Long COVID.

Podcasts

Using the new RSV vaccine in practice

A/Prof Michael Woodward AM outlines the challenges associated with getting older people optimally protected.

Podcasts

Adult vaccination – What’s new? – Lecture

A/Prof Michael Woodward AM outlines the challenges associated with getting older people optimally protected.

Clinical Articles

Vaccine mandate for health workers in NSW likely to end

Months after COVID vaccines were introduced in 2021, governments and private organisations mandated them for various groups. Health and aged care workers were among the first to need two doses to keep their jobs.

Clinical Articles

Tapeworm in bacon-lover’s brain presents as migraine

A middle-aged man from Florida with a history of migraines saw his GP. After the CT scan, something alarming was revealed: his brain was infested with tapeworm cysts...

Videos

Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).¹

Clinical Articles

COVID causes cognitive decline, drops in IQ

From the very early days of the pandemic, brain fog emerged as a significant health condition that many experience after COVID-19.

Videos

Understanding long COVID

Prof Andrew Lloyd answers questions on what exactly long COVID is, and how it is diagnosed. And most importantly, how it is managed at a general practice level.

Infectious diseases

From FLiRT to FLuQE: what to know about the latest COVID variants on the rise

The latest variant is nicknamed “FLuQE”, and is reportedly gaining traction in Australia and other countries. So what is there to know about FLuQE?

COVID & Bird Flu update – New variants, new vax schedule, antivirals

Prof Adrian Esterman provides relevant updates for COVID, respiratory infections, flu, and the latest in antivirals.

First human bird flu case reported in Victoria

Here’s what we know so far...

AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation

The development has been covered in various media outlets as primarily related to the known “adverse events”, namely the small risk of blood clots. However, other factors are far more likely to be driving this decision...

Long COVID update

Listen to the latest on Long COVID, with Dr Gary Grohmann, where we address the important considerations for Long COVID, what we know now, and how to treat, prevent and reduce the severity of Long COVID.

Using the new RSV vaccine in practice

A/Prof Michael Woodward AM outlines the challenges associated with getting older people optimally protected.

Adult vaccination – What’s new? – Lecture

A/Prof Michael Woodward AM outlines the challenges associated with getting older people optimally protected.

Vaccine mandate for health workers in NSW likely to end

Months after COVID vaccines were introduced in 2021, governments and private organisations mandated them for various groups. Health and aged care workers were among the first to need two doses to keep their jobs.

Tapeworm in bacon-lover’s brain presents as migraine

A middle-aged man from Florida with a history of migraines saw his GP. After the CT scan, something alarming was revealed: his brain was infested with tapeworm cysts...

Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).¹

COVID causes cognitive decline, drops in IQ

From the very early days of the pandemic, brain fog emerged as a significant health condition that many experience after COVID-19.

Understanding long COVID

Prof Andrew Lloyd answers questions on what exactly long COVID is, and how it is diagnosed. And most importantly, how it is managed at a general practice level.

Get the app

Site

Company

Connect

Legal

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Infectious diseases

The latest variant is nicknamed “FLuQE”, and is reportedly gaining traction in Australia and other countries. So what is there to know about FLuQE?

Prof Adrian Esterman provides relevant updates for COVID, respiratory infections, flu, and the latest in antivirals.

Here’s what we know so far...

The development has been covered in various media outlets as primarily related to the known “adverse events”, namely the small risk of blood clots. However, other factors are far more likely to be driving this decision...

Listen to the latest on Long COVID, with Dr Gary Grohmann, where we address the important considerations for Long COVID, what we know now, and how to treat, prevent and reduce the severity of Long COVID.

A/Prof Michael Woodward AM outlines the challenges associated with getting older people optimally protected.

A/Prof Michael Woodward AM outlines the challenges associated with getting older people optimally protected.

Months after COVID vaccines were introduced in 2021, governments and private organisations mandated them for various groups. Health and aged care workers were among the first to need two doses to keep their jobs.

A middle-aged man from Florida with a history of migraines saw his GP. After the CT scan, something alarming was revealed: his brain was infested with tapeworm cysts...

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).1

From the very early days of the pandemic, brain fog emerged as a significant health condition that many experience after COVID-19.

Prof Andrew Lloyd answers questions on what exactly long COVID is, and how it is diagnosed. And most importantly, how it is managed at a general practice level.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Extra Details

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).¹